Physician profile
Rinal Patel
NPI 1982918025
$1,136.98
in general payments reported to CMS, 2019-2025
20 companies · $92.16 in 2025
The $92.16 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $73.63 · 2021: $146 · 2022: $55.25 · 2023: $195 · 2024: $576 · 2025: $92.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $190.61 | 2021-2023 | Freestyle Libre |
| Madrigal Pharmaceuticals | $138.29 | 2024 | Rezdiffra, Resmetirom |
| Esperion Therapeutics, INC. | $127.56 | 2024 | Nexletol, Nexlizet |
| Lilly USA, LLC | $119.36 | 2020-2024 | Mounjaro, Zepbound |
| Novo Nordisk INC | $97.42 | 2024 | Sogroya |
| Tandem Diabetes Care, INC. | $71.10 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $57.71 | 2023-2024 | Dexcom G6 Transmitter |
| Shockwave Medical, INC | $49.06 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $34.86 | 2022 | |
| Abbvie INC. | $31.65 | 2021-2025 | |
| Ascensia Diabetes Care US INC. | $31.15 | 2025 | |
| Cequr Corporation | $30.61 | 2024 | Cequr Simplicity |
| Exact Sciences Corporation | $24.06 | 2023 | Cologuard Collection Kit |
| Insulet Corporation | $22.71 | 2021 | |
| Amarin Pharma, INC. | $21.91 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $21.62 | 2024 | |
| Antares Pharma, INC. | $20.39 | 2022 | |
| Corcept Therapeutics | $18.40 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.88 | 2021 | |
| Eisai INC. | $11.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rinal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.